Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InteliCare HoldingsASX:ICR Days Sales Outstanding is 28.18 as of Jun. 2026, which is 74% below its 10-year median of 109.92. The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, InteliCare Holdings ranks better than 59.79% on this metric.
The historical rank and industry rank for InteliCare Holdings's Days Sales Outstanding or its related term are showing as below:
ASX:ICR'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.52 Med: 109.92 Max: 247.87
Current: 36.64
During the past 9 years, InteliCare Holdings's highest Days Sales Outstanding was 247.87. The lowest was 32.52. And the median was 109.92.
ASX:ICR's Days Sales Outstanding is ranked better than 59.79% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 45.78
vs ASX:ICR: 36.64
InteliCare Holdings's Days Sales Outstanding
declined
from Jun. 2025 (76.09) to Jun. 2026 (28.18).
InteliCare Holdings (ASX:ICR) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
InteliCare Holdings Days Sales Outstanding Related Terms
InteliCare Holdings Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for InteliCare Holdings's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ICR vs VEEV, BTSG, TEM: Days Sales Outstanding Comparison
For the Health Information Services subindustry, InteliCare Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InteliCare Holdings Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InteliCare Holdings's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where InteliCare Holdings's Days Sales Outstanding falls into.
InteliCare Holdings Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InteliCare Holdings (ASX:ICR) has a Days Sales Outstanding of 28.18 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on InteliCare Holdings and its competitors. This is 74% below median its historical median of 109.92. Over the past decade, InteliCare Holdings' Days Sales Outstanding has ranged from 32.52 to 247.87. According to the industry distribution chart, InteliCare Holdings ranks #267 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 40.2%.
Is InteliCare Holdings' Days Sales Outstanding too high?
InteliCare Holdings' current Days Sales Outstanding of 28.18 is 74% below median its 10-year median of 109.92. Over the past 10 years, this metric has ranged from a low of 32.52 to a high of 247.87. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.78. InteliCare Holdings' value of 28.18 is 38.4% below this industry median. Based on the distribution chart, InteliCare Holdings ranks #267 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does InteliCare Holdings' Days Sales Outstanding compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, InteliCare Holdings ranks #267 out of 664 companies for Days Sales Outstanding. This puts InteliCare Holdings in the upper half of its industry. The industry median Days Sales Outstanding is 45.78. InteliCare Holdings' value of 28.18 is 38.4% below this benchmark. Historically, InteliCare Holdings' own Days Sales Outstanding has ranged from 32.52 to 247.87 over the past decade. While the company's 10-year median is 109.92 vs. the industry median of 45.78, InteliCare Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.78, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InteliCare Holdings's current Days Sales Outstanding of 28.18 is 38.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on InteliCare Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InteliCare Holdings's current Days Sales Outstanding is 28.18, which is 74% below median its own 10-year median of 109.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InteliCare Holdings stock overvalued right now?
Based on GuruFocus' analysis, InteliCare Holdings (ASX:ICR) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.02 — trading 23.3% below its estimated fair value. The current Days Sales Outstanding is 28.18, which is 74% below median its 10-year median of 109.92 and 38.4% below the Healthcare Providers & Services industry median of 45.78. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For InteliCare Holdings (ASX:ICR), the current Days Sales Outstanding is 28.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
InteliCare Holdings Ltd is an Australian firm engaged in the Production of a predictive analytics solution for care providers in the aged care, disability and healthcare sectors, Sales and marketing and Research and development activities. Its platform provides families and caregivers with a real-time view of the well-being of people in an independent living environment. The product portfolio includes InteliCare Hub, Smart sensors, Downloadable Applications, and Optional Duress Pendants. Substantial revenue comes from hardware sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ICR has been successfully added to your 
